Mary T Szela Med Tech Acquisition Corp (MTACW) insider trading activity

MTACW Quotes by TradingView

Mary T Szela is CEO AND PRESIDENT of MedTech Acquisition Corp. Currently has a direct ownership of 384,677 shares of MTACW, which is worth approximately $84,628. The most recent transaction as insider was on Sep 13, 2024, when has been sold 7,295 shares (Common Stock) at a price of $4.92 per share, resulting in proceeds of $35,891. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 385K
5.43% 3M change
n/a 12M change
Total Value Held $84,628

Mary T Szela Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
BUY
Open market or private purchase
$35,891 $4.92 p/Share
7,295 Added 1.86%
384,677 Common Stock
Sep 12 2024
BUY
Open market or private purchase
$39,104 $5.2 p/Share
7,520 Added 1.95%
377,382 Common Stock
Sep 10 2024
BUY
Open market or private purchase
$24,850 $4.97 p/Share
5,000 Added 1.33%
369,862 Common Stock
Feb 13 2024
BUY
Grant, award, or other acquisition
-
84,899 Added 18.88%
364,862 Common Stock

Also insider at

CHRS
Coherus BioSciences, Inc. Healthcare
Director
RXDX
Prometheus Biosciences, Inc. Healthcare
Director
KURA
Kura Oncology, Inc. Healthcare
OMGA
Omega Therapeutics, Inc. Healthcare
MTS

Mary T Szela

CEO AND PRESIDENT
San Diego, CA

Track Institutional and Insider Activities on MTACW

Follow MedTech Acquisition Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTACW shares.

Notify only if

Insider Trading

Get notified when an Med Tech Acquisition Corp insider buys or sells MTACW shares.

Notify only if

News

Receive news related to MedTech Acquisition Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MTACW